| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16,000 | 18 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 18 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 17:00 |
| KYMR | Kymera Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:15 |
| KYMR | Kymera Therapeutics, Inc. | 06 Jul 2022 | 1 | $0 | 4 | Director | 08 Jul 2022, 16:10 |
| KYMR | Kymera Therapeutics, Inc. | 06 Jul 2022 | 0 | $0 | 3 | Director | 08 Jul 2022, 16:05 |